Sangamo Reports Presentation of New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storage Disorders at ASGCT
May 18, 2015 at 07:21 AM EDT
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that new data from the company's proprietary ZFP Therapeutic® programs in disease ...